Jeffery H. Moran

High Impact

Assistant Professor

UAMS primary University of Arkansas

Also affiliated: Lawrence Livermore National Laboratory (2012); Arkansas Children's Hospital (2011–2021); University of Helsinki (2009); Monroe University (2013); Central Michigan University (2020); Universidad de Salamanca (1986); University of Toronto (1965–1966); Washington University in St. Louis (2009); University of Michigan (2012); University of Arkansas Medical Center (2018); Toronto General Hospital (1965–1966); Center for Environmental Health (2004); Cayman Chemical (United States) (2012); Arkansas Cardiology (2012); nPoint (United States) (2021–2026); Michigan United (2020); Arkansas State Crime Laboratory (2011–2012); Hospital de Cruces (1987); Jeffrey Modell Foundation (2013); Arkansas Department of Agriculture (2013–2025); Public Risk Management Association (2006); Arkansas Department of Health (2007–2018)

Faculty Researcher

Pharmacology & Toxicology, College of Medicine

29 h-index 84 pubs 3,777 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Jeffery H. Moran investigates the pharmacological effects and toxicity of various substances, with a particular focus on novel synthetic opioids and cannabinoids. His research explores the antinociceptive properties, dependence potential, and withdrawal symptoms associated with compounds like furanyl fentanyl and acryl fentanyl in preclinical models. Moran also studies the pharmacodynamics and metabolism of therapeutic agents, including the deuterated form of buprenorphine, examining its resistance to metabolism into active metabolites in rats.

His work extends to the development and validation of analytical methodologies for forensic investigations, such as hands-free urine testing technology for drug-facilitated crime analysis. Moran also contributes to medical education through curriculum development for undergraduate students and has published on topics ranging from acetaminophen safety in patients with cirrhosis to the pharmacokinetics of bleomycin in vascular malformations. His scholarship metrics include an h-index of 29 and over 3,700 citations, reflecting a significant body of published work.

Metrics

h-index: 29
Publications: 84
Citations: 3,777

Selected Publications

Interoceptive effects of N1-substituted lysergamides in rats: role of agonist affinity at 5-HT receptors and in vivo metabolism to lysergic acid diethylamide (LSD) (2026)

Journal of Pharmacology and Experimental Therapeutics DOI OpenAlex
Co-occurring substance use disorders and the compounding effect of kratom on serious mental illness, US, 2021–2023 (2026)

The American Journal of Drug and Alcohol Abuse DOI OpenAlex
Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses (2026)

Chemical Research in Toxicology DOI OpenAlex
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)

Neuropharmacology 4 citations DOI OpenAlex
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)

Drug and Alcohol Dependence 5 citations DOI OpenAlex
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations (2023)

Chemical Research in Toxicology 5 citations DOI OpenAlex
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2023)

Frontiers in Pharmacology 4 citations DOI OpenAlex
Development of a clinical and translational research curriculum for undergraduate students (2023)

Journal of Clinical and Translational Science 7 citations DOI OpenAlex
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2022)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations (2022)

Pediatric Blood & Cancer 13 citations DOI OpenAlex
The Spice of Death (2021)

Pediatric Emergency Care 6 citations DOI OpenAlex
Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis (2021)

Hepatology Communications 24 citations DOI OpenAlex
55715 Quantification of Neonatal THC Exposure Following Prenatal Marijuana Use (2021)

Journal of Clinical and Translational Science DOI OpenAlex
Modifying laboratory testing via home brew during the COVID-19 pandemic (2021)

Journal of Clinical and Translational Science 3 citations DOI OpenAlex
In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome (2019)

Journal of Pharmacology and Experimental Therapeutics 24 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

Reduced Temperature Thermal Ablation for HCC and other Liver Tumors NIH Co-Investigator
Metabolomics of menthol cigarette smoking and risk for aggressive prostate cancer among African-American men US Department of Defense Principal Investigator
HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial Clinical Site NIH Co-Investigator
Synthetic Cannabinoid Toxicity: Role of Biotransformation NIH Co-Investigator